Sugi Predict

Sugi Predict / Compounds / SCHEMBL891536

SCHEMBL891536

SCHEMBL891536

CC(=O)OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.69
▸ CCNB1 P14635 1/20 0.69
▸ LDHA P00338 1/20 0.50
▸ EPHX2 P34913 4/20 0.47
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ PRKCB P05771 1/20 0.38
▸ PRKCA P17252 1/20 0.38
▸ PRKCH P24723 1/20 0.38
▸ PRKCI P41743 1/20 0.38
▸ PRKCE Q02156 1/20 0.38
▸ PRKCQ Q04759 1/20 0.38
▸ PRKCZ Q05513 1/20 0.38
▸ PRKCD Q05655 1/20 0.38
▸ PRKD1 Q15139 1/20 0.38
▸ ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29279441 1.00 CDK1 (0.69) CDK1CCNB1LDHAEPHX2CA2
SCHEMBL28010776 0.99 CDK1 (0.67) CDK1CCNB1LDHAEPHX2CA2
Ammonia Solution, Strong SCHEMBL190257 0.99 CDK1 (0.67) CDK1CCNB1LDHAEPHX2CA2
Water SCHEMBL27148070 0.98 CDK1 (0.66) CDK1CCNB1LDHAEPHX2CA2
SCHEMBL27876247 0.91 CDK1 (0.66) CDK1CCNB1LDHAEPHX2CA2
SCHEMBL3134207 0.90 CDK1 (0.72) CDK1CCNB1LDHAEPHX2CA2
SCHEMBL9619718 0.90 CDK1 (0.72) CDK1CCNB1LDHAEPHX2CA2
SCHEMBL27473308 0.90 CDK1 (0.72) CDK1CCNB1LDHAEPHX2CA2
Benzoic Acid SCHEMBL28236823 0.90 CDK1 (0.57) CDK1CCNB1LDHAEPHX2CA2
SCHEMBL15756382 0.89 CDK1 (0.70) CDK1CCNB1LDHAEPHX2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4413074-A1 ARTICLES CONTAINING MELT PROCESSABLE CELLULOSE ESTER COMPOSITIONS COMPRISING AMORPHOUS BIOFILLER Eastman Chemical Company (US) 2024-08-14 — — EP claimed
EP-3394197-B1 METHOD FOR PRODUCING COLORLESS AND AGING-RESISTANT, POLYACRYLATE-BASED PRESSURE-SENSITIVE ADHESIVE COMPOUNDS TESA SE (DE) 2024-06-12 — — EP claimed
CN-114437146-B Production process of sucralose-6-acetate 福州大学 2023-12-08 — — CN claimed
WO-2023059853-A1 ARTICLES CONTAINING MELT PROCESSABLE CELLULOSE ESTER COMPOSITIONS COMPRISING AMORPHOUS BIOFILLER EASTMAN CHEMICAL COMPANY (US) 2023-04-13 — — WO claimed
CN-115590135-A Essence, application thereof and carbonated beverage containing essence 恒枫食品科技有限公司（CN） 2023-01-13 — — CN claimed
CN-115463069-A Multi-effect toothpaste for repairing stomatitis and preparation method thereof 斯钦 2022-12-13 — — CN claimed
CN-111281817-B Preparation method of water-containing bioactive glass toothpaste 云南白药集团健康产品有限公司 2022-08-30 — — CN claimed
US-20220265830-A1 LONG-ACTING FORMULATIONS AND VEHICLES DURECT CORPORATION (US) 2022-08-25 — — US claimed
US-20220257619-A1 LONG-ACTING FORMULATIONS OF TENOFOVIR ALAFENAMIDE DURECT CORPORATION 2022-08-18 — — US claimed
CN-114848530-A Pet bio-enzyme deodorization spray 胡银艳 2022-08-05 — — CN claimed
EP-0610063-B1 Regioselective enzymatic deacylation of sucrose esters in anhydrous organic media MCNEIL PPC INC (US) 2000-05-03 — — EP claimed
CN-1246342-A Method for producing garlic essence capsule XIANG DAORONG (CN) 2000-03-08 — — CN claimed
US-5897876-A A WATER-IN-OIL EMULSION COMPRISING A CONTINUOUS HYDROPHOBIC PHASE AND A DISCONTINUOUS AQUEOUS HYDROPHILIC PHASE, SURFACTANT DISPERSANTS AND ACTIVE DRUG FOR ORAL DELIVERY SHIRE LABORATORIES INC. (US) 1999-04-27 — — US claimed
EP-0869170-A2 Laundry detergent formulation Robert McBride Ltd (GB) 1998-10-07 — — EP claimed
CN-1147044-A Method for manufacturing mica sheet transfer paper HANTUO COMMODITY ADVERTISEMENT (CN) 1997-04-09 — — CN claimed
US-5445951-A Regioselective enzymatic deacylation of sucrose esters in anhydrous organic media MCNEIL-PPC, INC. (US) 1995-08-29 — — US claimed
EP-0610063-A2 Regioselective enzymatic deacylation of sucrose esters in anhydrous organic media McNEIL-PPC, INC. (US) 1994-08-10 — — EP claimed
WO-1993010187-A1 AGRICULTURAL BIODEGRADABLE PLASTICS INTERNATIONAL OPTICAL TELECOMMUNICATIONS, INC. (US) 1993-05-27 — — WO claimed
US-5205863-A Agricultural biodegradable plastics INTERNATIONAL COMMUNICATIONS & ENERGY (US) 1993-04-27 — — US claimed
EP-0260978-A2 Process for the preparation of penta-0-acetyl sucrose TATE & LYLE PUBLIC LIMITED COMPANY (GB) 1988-03-23 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220265830-A1 LONG-ACTING FORMULATIONS AND VEHICLES NPY5R, GNRHR, VEGFA CDK1 4700/4885CCNB1 4384/4885LDHA 3669/4885
US-20220257619-A1 LONG-ACTING FORMULATIONS OF TENOFOVIR ALAFENAMIDE ADA, ADAR, TYMP CDK1 3590/4885CCNB1 4422/4885LDHA 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.